Information  X 
Enter a valid email address

Oxford Biomedica PLC Ord 1P (OXB)

Date Time Source Announcement
17 Sep 2020 7:00 am
RNS
Interim Results
01 Sep 2020 9:33 am
RNS
Total Voting Rights
  7:00 am
RNS
Master Supply and Development Agreement with AZ
27 Aug 2020 7:00 am
RNS
Notice of Interim Results
25 Aug 2020 4:46 pm
RNS
Block listing Application
03 Aug 2020 9:41 am
RNS
Total Voting Rights
  7:00 am
RNS
OXB signs DMLA with Beam Therapeutics
31 Jul 2020 7:00 am
RNS
OXB Signs Clinical Supply Agreement with Axovant
20 Jul 2020 4:23 pm
RNS
OXB notes interim results from AZ on AZD1222
03 Jul 2020 10:45 am
RNS
Director Dealings / Market Share Purchase
02 Jul 2020 3:39 pm
RNS
Director Dealings / Market Share Purchase
  1:34 pm
RNS
Director Dealings / Market Share Transactions
01 Jul 2020 6:30 pm
RNS
Holdings in Company
  3:44 pm
RNS
Block listing Return
  9:13 am
RNS
Total Voting Rights
30 Jun 2020 3:23 pm
RNS
Grant of options
25 Jun 2020 9:44 am
RNS
Holding(s) in Company
24 Jun 2020 11:45 am
RNS
Holdings in Company
  9:54 am
RNS
Director Dealings / Share Disposal - Replacement
23 Jun 2020 4:46 pm
RNS
Result of Annual General Meeting
  2:47 pm
RNS
Admission of shares and Total Voting Rights.
  7:00 am
RNS
Annual General Meeting
19 Jun 2020 3:26 pm
RNS
Information in Relation to Annual General Meeting
  7:00 am
RNS
Result of Placing
18 Jun 2020 5:33 pm
RNS
Proposed Placing of new Ordinary Shares
08 Jun 2020 4:01 pm
RNS
Update on Sanofi Ophthalmology Programmes
  7:00 am
RNS
Five Year Collaboration Agreement signed with VMIC
01 Jun 2020 9:06 am
RNS
Total Voting Rights
  7:00 am
RNS
Dr Roch Doliveux appointed Non-Executive Chairman
28 May 2020 12:16 pm
RNS
Clinical & Commercial Supply Agreement with AZ
27 May 2020 11:26 am
RNS
Director Dealings / Market Share Purchase
22 May 2020 5:28 pm
RNS
2019 Annual report and Accounts & AGM Notification
20 May 2020 2:34 pm
RNS
Holding(s) in Company
13 May 2020 6:02 pm
RNS
Holding(s) in Company
  7:00 am
RNS
OXB receives approval for first two Oxbox suites
11 May 2020 4:25 pm
RNS
PDMR Dealings / Market Share sale
06 May 2020 12:36 pm
RNS
Directors Dealings / Market Share Purchases
  7:00 am
RNS
Preliminary Results
01 May 2020 9:05 am
RNS
Total Voting Rights
28 Apr 2020 1:04 pm
RNS
Compliance with LR 9.2.6ER(1)
24 Apr 2020 11:48 am
RNS
Director/PDMR Shareholding
23 Apr 2020 8:38 am
RNS
Holding(s) in Company
22 Apr 2020 12:03 pm
RNS
Kymriah receives FDA RMAT designation in FL
20 Apr 2020 4:49 pm
RNS
Holding(s) in Company
16 Apr 2020 3:17 pm
RNS
Notice of Results Update
08 Apr 2020 7:00 am
RNS
Oxford Biomedica joins COVID-19 vaccine Consortium
01 Apr 2020 9:31 am
RNS
Total Voting Rights
25 Mar 2020 1:06 pm
RNS
Director Dealings / Market Share Purchase
20 Mar 2020 9:56 am
RNS
Director/PDMR Shareholding
18 Mar 2020 7:00 am
RNS
Oxford Biomedica Business Update
  7:00 am
RNS
License & Supply Agreement with Juno Therapeutics
02 Mar 2020 9:22 am
RNS
Total Voting Rights
26 Feb 2020 5:55 pm
RNS
Director Dealings / Market Share Purchase
03 Feb 2020 5:04 pm
RNS
Class 2 Transaction Announcement
  11:56 am
RNS
Total Voting Rights
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t